Frontiers in Medicine (Nov 2021)

Discrimination of SARS-CoV-2 Infections From Other Viral Respiratory Infections by Scent Detection Dogs

  • Nele Alexandra ten Hagen,
  • Friederike Twele,
  • Sebastian Meller,
  • Paula Jendrny,
  • Claudia Schulz,
  • Maren von Köckritz-Blickwede,
  • Maren von Köckritz-Blickwede,
  • Ab Osterhaus,
  • Hans Ebbers,
  • Isabell Pink,
  • Tobias Welte,
  • Michael Peter Manns,
  • Thomas Illig,
  • Anahita Fathi,
  • Anahita Fathi,
  • Anahita Fathi,
  • Marylyn Martina Addo,
  • Marylyn Martina Addo,
  • Marylyn Martina Addo,
  • Andreas Nitsche,
  • Andreas Puyskens,
  • Janine Michel,
  • Eva Krause,
  • Rosina Ehmann,
  • Albrecht von Brunn,
  • Albrecht von Brunn,
  • Christiane Ernst,
  • Katrin Zwirglmaier,
  • Roman Wölfel,
  • Alexandra Nau,
  • Eva Philipp,
  • Michael Engels,
  • Esther Schalke,
  • Holger Andreas Volk

DOI
https://doi.org/10.3389/fmed.2021.749588
Journal volume & issue
Vol. 8

Abstract

Read online

Background: Testing of possibly infected individuals remains cornerstone of containing the spread of SARS-CoV-2. Detection dogs could contribute to mass screening. Previous research demonstrated canines' ability to detect SARS-CoV-2-infections but has not investigated if dogs can differentiate between COVID-19 and other virus infections.Methods: Twelve dogs were trained to detect SARS-CoV-2 positive samples. Three test scenarios were performed to evaluate their ability to discriminate SARS-CoV-2-infections from viral infections of a different aetiology. Naso- and oropharyngeal swab samples from individuals and samples from cell culture both infected with one of 15 viruses that may cause COVID-19-like symptoms were presented as distractors in a randomised, double-blind study. Dogs were either trained with SARS-CoV-2 positive saliva samples (test scenario I and II) or with supernatant from cell cultures (test scenario III).Results: When using swab samples from individuals infected with viruses other than SARS-CoV-2 as distractors (test scenario I), dogs detected swab samples from SARS-CoV-2-infected individuals with a mean diagnostic sensitivity of 73.8% (95% CI: 66.0–81.7%) and a specificity of 95.1% (95% CI: 92.6–97.7%). In test scenario II and III cell culture supernatant from cells infected with SARS-CoV-2, cells infected with other coronaviruses and non-infected cells were presented. Dogs achieved mean diagnostic sensitivities of 61.2% (95% CI: 50.7–71.6%, test scenario II) and 75.8% (95% CI: 53.0–98.5%, test scenario III), respectively. The diagnostic specificities were 90.9% (95% CI: 87.3–94.6%, test scenario II) and 90.2% (95% CI: 81.1–99.4%, test scenario III), respectively.Conclusion: In all three test scenarios the mean specificities were above 90% which indicates that dogs can distinguish SARS-CoV-2-infections from other viral infections. However, compared to earlier studies our scent dogs achieved lower diagnostic sensitivities. To deploy COVID-19 detection dogs as a reliable screening method it is therefore mandatory to include a variety of samples from different viral respiratory tract infections in dog training to ensure a successful discrimination process.

Keywords